Effects of black race on forearm resistance vessel function

被引:68
作者
Kahn, DF
Duffy, SJ
Tomasian, D
Holbrook, M
Rescorl, L
Russell, J
Gokce, N
Loscalzo, J
Vita, JA
机构
[1] Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA
关键词
endothelium; hypertension; essential; race; blacks; oxidative stress;
D O I
10.1161/01.HYP.0000024571.69634.ED
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Presentation, response to therapy, and clinical outcome in hypertension differ according to race, and these observations could relate to differences in microvascular function. We examined forearm microvascular function in age-matched black (n = 56) and white subjects (n = 62) using intra-arterial agonist infusion and venous occlusion plethysmography. In normotensive subjects (n = 70; 34 black and 36 white normotensives), methacholine-, sodium nitroprusside-, and verapamil-induced vasodilation was equivalent in black and white subjects. In hypertensive subjects (n = 48; 22 black and 26 white hypertensives), the vasodilator response to methacholine was markedly lower in black subjects compared with white subjects (P < 0.001). The vasodilator responses to sodium nitroprusside and verapamil, however, were equivalent in black and white hypertensive subjects. Acute ascorbic acid infusion improved the methacholine response equally in black and white hypertensive patients, suggesting that a difference in a rapidly reversible form of oxidative stress does not explain these findings. Thus, the present study demonstrates important racial differences in vascular function and a marked impairment in endothelial vasomotor function in black patients with hypertension. Further studies will be required to elucidate the mechanisms and determine whether these insights will lead to more appropriately tailored management of hypertension and its complications.
引用
收藏
页码:195 / 201
页数:7
相关论文
共 33 条
[21]   ATHEROSCLEROSIS, OXIDATIVE STRESS, AND ANTIOXIDANT PROTECTION IN ENDOTHELIUM-DERIVED RELAXING FACTOR ACTION [J].
KEANEY, JF ;
VITA, JA .
PROGRESS IN CARDIOVASCULAR DISEASES, 1995, 38 (02) :129-154
[22]   ATTENUATION OF ISOPROTERENOL-MEDIATED VASODILATATION IN BLACKS [J].
LANG, CC ;
STEIN, CM ;
BROWN, RM ;
DEEGAN, R ;
NELSON, R ;
HE, HB ;
WOOD, M ;
WOOD, AJJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (03) :155-160
[23]   IMPAIRED ENDOTHELIUM-DEPENDENT VASODILATION IN PATIENTS WITH ESSENTIAL-HYPERTENSION - EVIDENCE THAT NITRIC-OXIDE ABNORMALITY IS NOT LOCALIZED TO A SINGLE SIGNAL-TRANSDUCTION PATHWAY [J].
PANZA, JA ;
GARCIA, CE ;
KILCOYNE, CM ;
QUYYUMI, AA ;
CANNON, RO .
CIRCULATION, 1995, 91 (06) :1732-1738
[24]   EFFECT OF ANTIHYPERTENSIVE TREATMENT ON ENDOTHELIUM-DEPENDENT VASCULAR RELAXATION IN PATIENTS WITH ESSENTIAL-HYPERTENSION [J].
PANZA, JA ;
QUYYUMI, AA ;
CALLAHAN, TS ;
EPSTEIN, SE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 21 (05) :1145-1151
[25]   African American patients and heart disease [J].
Parmley, WW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (05) :1577-1577
[26]   Prognostic significance of endothelial dysfunction in hypertensive patients [J].
Perticone, F ;
Ceravolo, R ;
Pujia, A ;
Ventura, G ;
Iacopino, S ;
Scozzafava, A ;
Ferraro, A ;
Chello, M ;
Mastroroberto, P ;
Verdecchia, P ;
Schillaci, G .
CIRCULATION, 2001, 104 (02) :191-196
[27]   Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension [J].
Sherman, DL ;
Keaney, JF ;
Biegelsen, ES ;
Duffy, SJ ;
Coffman, JD ;
Vita, JA .
HYPERTENSION, 2000, 35 (04) :936-941
[28]   Vasodilation in black Americans: Attenuated nitric oxide-mediated responses [J].
Stein, CM ;
Lang, CC ;
Nelson, R ;
Brown, M ;
Wood, AJJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (04) :436-443
[29]   Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension [J].
Taddei, S ;
Virdis, A ;
Ghiadoni, L ;
Magagna, A ;
Salvetti, A .
CIRCULATION, 1998, 97 (22) :2222-2229
[30]   Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants [J].
Tanus-Santos, JE ;
Desai, M ;
Flockhart, DA .
PHARMACOGENETICS, 2001, 11 (08) :719-725